Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Classement en actions #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Prix de l'action
$3.28
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$5.10B
Changement (1 jour)
0.00%
Changement (1 an)
-49.70%
Pays
TW
Échange Caliway Biopharmaceuticals Co. L (6919)

Catégorie

Historique du rendement du dividende pour Caliway Biopharmaceuticals Co. L (6919)
Le rendement du dividende (TTM) de Caliway Biopharmaceuticals Co. L (symbole boursier : 6919) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Caliway Biopharmaceuticals Co. L (6919) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH